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ABSTRACT: A new enantioselective desymmetrizing Mizoroki-Heck reaction is reported. The process affords high yields and 
enantioselectivities of tricyclic structures containing all-carbon quaternary stereocenters. The substrates for the reaction are effi-
ciently synthesized from Birch reduction-alkylation of benzoic acid and benzoate esters.  
Recent structural analysis of drug candidates has discovered 
that successful drugs have a higher percent of sp3 carbons and 
are more likely to contain stereogenic centers. In a series of 
articles entitled “Escape from Flatland,”1, 2 Lovering and col-
leagues analyzed drug development candidates since 1980 and 
discovered a higher frequency of sp3 carbons and chiral cen-
ters in successful drugs. Two reasons have been advanced to 
explain the better pharmaceutical profile of sp3 rich and chiral 
molecules: improved solubility2 and less promiscuous binding 
behavior1. 
In contrast to the apparent need for drug candidates with sp3 
carbons and chiral centers, the three most commonly used 
reactions by medicinal chemists remain amide bond formation, 
the Suzuki-Miyaura reaction and nucleophilic aromatic substi-
tution3.  These sp2 carbon-focused methodologies in combina-
tion with other popular and efficient cross coupling synthetic 
tools have likely contributed to the preponderance of flat aro-
matic structures in compound screening libraries.  To over-
come this limitation and assist in the development of better 
drug candidates, there is a pressing need for more efficient 
tools to construct chiral, non-planar structures.  
One of the most challenging sp3 stereocenters to construct is 
the all-carbon quaternary center4-7; and one popular and effi-
cient method for creating quaternary all-carbon stereocenters 
is the Mizoroki-Heck (Heck) reaction8. Many elegant enanti-
oselective applications of the Heck reaction have been de-
scribed9-11, but the full substrate scope of the asymmetric Heck 
reaction has yet to be explored, and important tools for the 
construction of complex bioactive structures remain to be de-
veloped. A recent popular approach to more general enantiose-
lective Heck reactions involves desymmetrization reactions5, 
12-14. Scheme 1 illustrates a collection of examples related to 
the current work, including desymmetrization examples by 
Shibasaki15, 16 and Feringa17, 18.  These procedures demonstrat-
ed modest to good yields and high enantioselectivities to poly-
cyclic ring structures, which are common components of suc-
cessful drugs19, 20.  
Scheme 1. Catalytic enantioselective Heck reactions.
 
Herein, we report a new desymmetrizing enantioselective 
Heck reaction, which has both high yields and enantioselectiv-
ities. The method complements recent work by Tang21 and 
Feringa, and expands the scope of the Shibasaki work being 
both more efficient and more stereoselective. In the process, a 
 tricyclic ring system is generated with an all-carbon quater-
nary stereocenter. In addition, the substrates are produced 
through an efficient Birch reduction-alkylation process with 
inexpensive benzoic acid or benzoate esters. Although this 
process is perfectly suited to the facile generation of cyclohex-
adiene desymmetrization substrates, previous work has almost 
exclusively used alkylation of the considerably more expen-
sive 2,5-cyclohexadiene-1-carboxylic acid15 or a 5-6 step se-
quence starting with cyclohexenone derivatives22-25.   
Our study began with the synthesis of various substrates us-
ing the Birch reduction-alkylation reaction (Table 1)26. Both 
benzoic acid and benzoate ester substrates were used. With 
benzoate esters, t-BuOH is added as a proton source to proto-
nate the radical anion intermediate. In all cases, a 2-iodo or 2-
triflate group was incorporated in the alkylating agent for later 
use in the Heck reaction. The Birch reduction-alkylation yields 
generally ranged from good to excellent with the 2-iodo deriv-
atives affording the highest yields (entry 1 and 7). The lowest 
yielding examples involved alkylating agents with 2-triflate 
and substituted benzene rings (entry 3 and 6). In these cases, 
there was considerable decomposition, including, not surpris-
ingly, from cleavage of the triflate group.  Although benzyl 
bromides were the alkylating agent of choice, we found the 
benzyl chloride better in some cases, including with benzoic 
acid reductive alkylations (entry 9) or in cases where the tri-
flate alkylating agent proved unstable as a benzyl bromide 
derivative (entry 6). Notably the benzyl halides used in the 
Birch reaction are some of the most complex used to date and 
the first example of an alkylating agent with an aryl triflate.  
Table 1. Birch reduction-alkylation reaction.  
 
entry R1 X Y         R2 yield (%)   compd 
1 Et I Br H 85 1a 
2 Et OTf Br H 54 1b 
3 Et OTf Br 4-Me 18 1c 
4 Et OTf Br 5-Me 78 1d 
5 Et OTf Br 6-Me 77 1e 
6 Et OTf Cl 4-Cl 28 1f 
7 t-Bu I Br H 96 1g 
8 t-Bu OTf Br H 79 1h 
9 H OTf Cl H 57 1i 
a t-BuOH added with benzoate ester substrates 
Initial Heck reaction studies were conducted with the 2-iodo 
substrates (Table 2), as they were more readily synthesized 
through the Birch reduction-alkylation. Extensive reaction 
screening was conducted to optimize ligands, bases, solvents 
and temperatures. Table 2 illustrates modifications to solvents, 
bases, Ag2CO3 equivalents, and reaction concentration, which 
lead to some of the more successful efforts. The Supporting 
Information (SI) has a complete account of the reaction 
screening. The reactions did afford efficient conversions (50-
90% yields) and the use of toluene or 1,4-dioxane with 
Ag2CO3 afforded the 1,3-diene product exclusively (cf. Table 
3 products). This was critical as, not surprisingly, the diene 
isomers had almost identical chromatographic properties and 
therefore the presence of both made enantioselectivity evalua-
tions difficult. An additional challenge was found with incom-
plete reactions as the iodo starting materials had similar chro-
matographic properties to the cyclized products. Nonetheless, 
despite significant optimization efforts, the best enantioselec-
tive ratio achieved was 88:12 (entry 5 and 10).  It should be 
noted that in this and all subsequent examples, the cis ring 
junction isomers were presumed to be formed, but the exact 
enantiomer has not been determined.  
Table 2. Aryl iodide Heck reaction optimization. 
 
entry solvent base time (h) result er 
1 DMF Ag2CO3 118 no rxn. - 
2 toluene Ag2CO3 137 2a 79:21 
3 1,4-dioxane  
(0.05 M) 
Ag2CO3 280 2a 84:16 
4 1,4-dioxane  
(0.2 M) 
Ag2CO3 67 2a 81:19 
5 1,4-dioxane Ag2CO3 137 2a 88:12 
6 1,4-dioxane Ag2CO3 
(1.0 equiv) 
1000 inc.a - 
7 1,4-dioxane Ag2CO3 
(4.0 equiv) 
87 2a 87:13 
8 1,4-dioxane Na2CO3b 153 2a 75:25 
9 1,4-dioxane Cy2NMeb 87 2a 81:19 
10c 1,4-dioxane Ag2CO3 137 2h 88:12 
a incomplete; b 2.0 equiv Ag3PO4 added as halide scavenger; c t-Bu 
ester used 
Although aryl halides have been successful in affording en-
antioselective Heck reactions (Scheme 1, Feringa and Tang 
work), there is good evidence that the most reliable path to 
high enantioselectivities in asymmetric Heck reactions is via a 
cationic palladium complex pathway10, 11. Cationic palladium 
complex formation was promoted with the aryl iodides 
through the use of silver salts (Table 2), however, we had 
reached a limit to the enantioselective gains from the silver. 
Consequently, we turned to aryl triflates, whose counteranion 
is much weaker than the halides and does not require silver 
salt sequestration to provide greater amounts of cationic palla-
dium complex. Table 3 details the exploratory work with aryl 
triflates which lead to the first reaction examples with enanti-
oselectivities exceeding 90%. Although 1,4-dioxane was the 
optimal solvent for the aryl iodide reactions, DMF worked 
best for the aryl triflates and, as a strong coordinating solvent, 
could provide cationic palladium complex stabilization27, 28. 
Without the need for silver in the Ag2CO3 base, Cy2NMe was 
determined to be the optimal base. One additional fortunate 
outcome of the aryl triflate substrates was the exclusive for-
mation of the 1,3-diene product in most all cases. As noted for 
Table 2 results, incomplete reactions were difficult to analyze 
due to the similar chromatographic properties of the triflate 
starting materials and the cyclized product. Although efforts 
 were made to reduce the Pd catalyst equivalents, lower 
amounts resulted in slower or incomplete reactions (cf. entries 
4 and 5 versus 6). While increasing the reaction temperature to 
accelerate the process degraded the enantioselectivity (cf. en-
try 9 versus 10 and 11); this is likely because it compromised 
the stability of the palladium-BINAP complex. Higher catalyst 
loadings for aryl triflate reactions with stable diphosphine 
bidentate ligands are relatively common29-31. These ligands 
form stable complexes, which critically and thoroughly control 
the chiral environment of the catalytic complex, but frequently 
lead to slow turnover in the process.  
Table 3. Aryl triflate Heck reaction optimization. 
 
entry cat. (mol %) temp 
(oC) 
time 
(h) 
result  er 
1 10 23100 229 no rxn. - 
2 10 23 215 2a/3a 
(68:32) 
- 
3 10 23 21 no rxn. - 
4 10 40 593 inc.a - 
5 5 + 5 (24 h) 40 593 inc. - 
6 20 40 162 2a 97:3 
7 10 60 428 inc. - 
8 5 + 5 (24 h) 60 593 inc. - 
9 20 60 39 2a 97:3 
10 10 80 39 2a 82:18 
11 5 + 5 (24 h) 80 39 2a 66:34 
12 20 80 39 2a/3a 
(81:19) 
- 
a incomplete 
Wth enantioselective ratios over 90%, studies turned to ex-
ploring the substrate scope with the optimal reaction condi-
tions. Two modifications were explored: Alternative ester 
derivatives and substituted aryl triflates. The ester derivatives 
were synthesized from the benzoic acid Birch reaction product 
(Table 1, entry 9), as illustrated in Scheme 2. Substituted aryl 
triflates were synthesized through the use of appropriately 
substituted 2-OTf-benzyl halide alkylating agents. These al-
kylating agents were synthesized in three steps from substitut-
ed salicylaldehydes (see SI).  
Scheme 2. Esterification reactions. 
 
Table 4 shows success with a range of ester derivatives. Me-
thyl, ethyl, t-butyl and benzyl all work efficiently. The ethyl 
derivative was run at 1 mmol scale and provided an even 
higher yield than the smaller scale exploratory reactions. Allyl 
and carboxylic acid derivatives (entries 6 and 7) both decom-
posed to diphenyl side product; presumably the result of de-
carboxylative oxidation of the cyclohexandiene-carboxylate 
core.  
Table 4. Ester derivative Heck reactions. 
 
entry R time 
(h) 
yield 
(%) 
er compd 
1 Me, 1j 15 76 98:2 2j 
2a Et, 1b 39 73 98:2 2a 
3b Et, 1b 39 86 97:3 2a 
4 t-Bu, 1h 38 74 97:3 2h 
5 Bn, 1l 44 72 97:3 2l 
6 allyl, 1k 41 dec.c - - 
7 OH, 1i 19 dec. - - 
a  0.08 mmol scale; b 1.0 mmol scale;  c decomposed 
Substituted benzene rings also afforded high yields and en-
antioselectivities (Table 5) for methyl and chloro substitution. 
Electron-withdrawing (NO2 and CF3) and electron-donating 
(OMe) groups failed to react. Substitution adjacent to the tri-
flate group created steric hindrance to the process that degrad-
ed the rate and enantioselectivity (entry 3).  
Table 5. Substituted aryl group Heck reactions.  
 
entry R time (h) yield (%) er compd 
1 4-Me, 1c 17 72 96:4 2c 
2 5-Me, 1d 219 77 98:2 2d 
3 6-Me, 1e 288 73 60:40 2e 
4 4-Cl, 1f 86 75 96:4 2f 
 
In conclusion, a new catalytic enantioselective desymme-
trizing Heck reaction has been achieved, and in most cases, it 
affords high yields and enantioselectivities in the construction 
of tricyclic rings with an all-carbon quaternary stereocenter. 
Modifications at the quaternary center and the aryl triflate ring 
are permitted. The process uses a Birch reduction-alkylation 
reaction to efficiently construct the desymmetrization substrate 
and is the first example of such an application.  
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